Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000902664-26-001156·Century Therapeutics, Inc.
Schedule 13G ownership disclosure
Century Therapeutics, Inc.
Common Stock, par value $0.0001 per share · CUSIP: 15673T100
Event date: 2025-12-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Point72 Asset Management, L.P.
Shares: 5,961,563.00 · Class: 6.8%
- Point72 Capital Advisors, Inc.
Shares: 5,961,563.00 · Class: 6.8%
- Steven A. Cohen
Shares: 5,961,563.00 · Class: 6.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-26-001156
- Form type
- SCHEDULE 13G/A
- Filer
- Century Therapeutics, Inc.
- CIK
- CIK 1850119
- Filed
- Feb 17, 2026
- Reporting period
- Dec 23, 2025
- Description
- Schedule 13G beneficial ownership